Optimized health care for subjects with type 1 diabetes in a resource constraint society: A three-year follow-up study from Pakistan

Table 2 Comparison of clinical measures from baseline to last follow up

Variables		Age (yr)
		0-5 yr	6-12 yr	13-18 yr	19 and above
HbA1c (%)	Baseline (n = 1428)	11.5 ± 2.04	10.7 ± 2.28	10.5 ± 2.76	9.6 ± 2.52
	End line (n = 516)	10.2 ± 2.12	8.9 ± 2.24	8.7 ± 2.49	8.5 ± 2.17
	P-value	0.026	< 0.0001	< 0.0001	< 0.0001
Systolic blood pressure (mmHg)	Baseline (n = 1428)	108.3 ± 20.8	105.4 ± 14.7	106.3 ± 14.7	108.2 ± 14.9
	End line (n = 1428)	92.4 ± 10.3	99.1 ± 13.3	105.3 ± 13.3	112.7 ± 14.2
	P-value	0.001	0.0002	0.500	0.001
Diastolic blood pressure (mmHg)	Baseline (n = 1428)	74.6 ± 11.2	72.9 ± 10.6	73.7 ± 10.5	74.3 ± 10
	End line (n = 1428)	65 ± 6.6	66.2 ± 7.7	71.3 ± 8.3	74.6 ± 8.5
	P-value	0.001	0.0004	0.002	0.747
Fasting blood sugar (mg/dL)	Baseline (n = 1428)	199.2 ± 109.4	266.4 ± 118.9	282.4 ± 107	266.20 ± 112.6
	End line (n = 1428)	77.0 ± 2.64	293.86 ± 105.57	270.96 ± 104.83	252.43 ± 117.13
	P-value	0.059	0.292	0.550	0.415
Random Blood Sugar (mg/dl)	Baseline (n = 1428)	326.2 ± 161.1	342.4 ± 149.7	360.3 ± 135.4	338.9 ± 131
	End line (n = 1428)	522.33 ± 267.54	479.24 ± 189.99	394.63 ± 171.36	354.86 ± 157.43
	P-value	0.002	<0.0001	0.138	0.476

Data presented as mean ± SD.